3Ohtsuka T, Nomori H, Horio H,et al. Radiological examination for peripheral lung cancers and benign nodules less than 10 mm[J]. Lung Cancer,2003,42(3) :291-296.
4Pro MP, Isabel T, Merrcedes P. The halo sign in computed tomogaphy images:differential diagnosis and correlation with pathology findings[J]. Arch Bmnconeumol, 2008,44: 386-392.
5Kaneko M ,Eguchi K,Ohmatsu H ,et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography[J]. Radiology, 1996,201 : 798-802.
6Takatoshi Aoki, Hajime Nakata,Hideyuki Watanabe,et al. Evolution of peripheral lung adenocarcinomas CT findings correlated with his- tology and tumor doubling time[J]. AJR, 2000,174(3) : 763-768.
7Gridelli C1, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst ,2003,95:362-372.
8Kosmidis PA, Kalofonos HP, Christodoulou C, et al. Paelitaxel and gem- citabine versus earboplatin and gemcitabine in patients with advanced non-small-celt lung cancer. A phase IIl study of the Hellenic Cooperative Oncology Group. Ann Oncol,2008,19 : 115-122.
9Rajeswaran A,Trojan A, Burnand B, et al. Efficacy and side effects of cis- platin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treat- ment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer.2008.59,1-11.
10Scagliotti GV,Pastorino U,Vansteenkiste JF,et al.Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.J Clin Oncol,2012,30:172-178.
